UBS upgraded Generali (ARZGY) to Buy from Sell with a price target of EUR 40, up from EUR 23.70. The firm says the company’s favorable business mix and capital strength will drive peer-leading earnings growth at an attractive share valuation.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARZGY:
- Generali upgraded to Outperform from Market Perform at Keefe Bruyette
- Generali price target raised to EUR 42 from EUR 40 at JPMorgan
- Generali price target raised to EUR 37.50 from EUR 36.10 at Berenberg
- Generali Reports Strong Growth in 2025 Earnings
- Generali SpA Earnings Call: Balancing Growth and Challenges